https://articles.mercola.com/sites/articles/archive/2021/12/21/understanding-covid-19.aspx

https://bnt-cdn.b-cdn.net/upload/videos/2021/12/bZuyRa3H5FUYi3DSpAep_15_e05d4d490ae44a33cacf34f748396d4b_video_480p_converted.mp4

Of the COVID-19 deaths in the U.S., none received adequate and/or early-enough treatment. At least 85% of COVID deaths were preventable
There are three components to SARS-CoV-2 infection: viral replication, cytokine storm and blood clotting, therefore necessitating a multidrug approach, and treatment must begin early to be effective
Research published in 2006 showed hydroxychloroquine reduced viral replication of SARS-CoV-1 (the original SARS virus). It also has well-established anti-inflammatory properties. These two properties help explain its usefulness against COVID-19
There were clear intentional efforts to prevent use of hydroxychloroquine against COVID-19, likely in an effort to make the COVID jabs appear necessary
You cannot get COVID-19 twice; those with natural immunity have robust, long-lasting immunity. The Pfizer COVID shot, meanwhile, has been shown to have undetectable effectiveness 201 days after the second dose and Moderna’s effectiveness reaches zero around day 121
If you could only listen to one podcast to get up to speed on COVD-19, you are in luck as one of the top clinicians in the world on understanding COVID-19, Dr. Peter McCullough, finally made his way to the largest podcast in the world, Joe Rogan and, as expected, it was epic. You will do yourself a serious disservice if you don't watch the entire, nearly three-hour, interview at normal speed.

McCullough is an internist, cardiologist and epidemiologist, and in this podcast, he reviews and summarizes what we know about the COVID jabs. McCullough also discusses the importance of early treatment, which has been universally suppressed and ignored from the start.

He's convinced, and states unequivocally in this interview, that of the COVID-19 deaths in the U.S., none received adequate and/or early-enough treatment. In short, people did not, and certainly don't now, need to die from this infection, barring some serious underlying condition.

It's treatable, and later variants, such as Delta and Omicron, appear generally milder than the original virus, resulting in even easier-to-treat illness. From early on, researchers and clinicians demonstrated that early treatment, be it with hydroxychloroquine, ivermectin or steroids and anticoagulants — in some combination — resulted in far better outcomes and saved lives.

When you just let the infection run its course without treatment, most COVID-19 patients were riddled with blood clots and other complications by the time they were hospitalized. According to McCullough, we know that at least 85% of all COVID deaths could have been avoided with early treatment.

Early Treatment Is Key
In August 2020, McCullough's landmark paper "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 Infection" was published online in the American Journal of Medicine.1

It was the first published report on how to treat COVID on an outpatient basis and described a comprehensive COVID treatment protocol for frontline doctors. Before this, there were about 4,000 papers discussing the potential benefit of various remedies, but none that actually sought to present a comprehensive protocol for treatment.

A follow-up paper, "Multifaceted Highly Targeted Sequential Multidrug Treatment of Early Ambulatory High-Risk SARS-CoV-2 Infection (COVID-19)" published in Reviews in Cardiovascular Medicine in December 2020,2 became the basis for an AAPS home treatment guide.

Importantly, McCullough and the team of collaborators he put together understood early on that there were three components to this infection: viral replication, cytokine storm and blood clotting, therefore necessitating a multidrug approach.

One drug that gained early attention was hydroxychloroquine, as research published in 2006 showed it reduced viral replication of SARS-CoV-1 (the original SARS virus). It also has well-established anti-inflammatory properties. It's been routinely used in the treatment of lupus, for example. But as explained by McCullough, there were clear intentional efforts to prevent use of the drug against COVID-19.

The U.S. government refused to release its stockpiles, and doctors were told they'd lose their medical license if they used it. The largest manufacturing plant of hydroxychloroquine even mysteriously burned down, and in South Africa, "mercenaries" were breaking into pharmacies and burning the drug.

Also...
Treatment Was Suppressed for a Reason
Questions About Reinfection Linger
Relative Versus Absolute Risk Reduction
Efficacy Rapidly Wanes
The Most Dangerous Injections in Medical History
Who's at Greatest Risk for COVID Jab Side Effects?
Consistent Data Point to Clear and Present Danger
Myocarditis Will Likely Be Widespread
Reject Boosters